We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

193 hedge funds and large institutions have $391M invested in ImmunityBio in 2024 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 63 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

143% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 21

37% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 46

17% more funds holding

Funds holding: 165 → 193 (+28)

10% more capital invested

Capital invested by funds: $357M → $391M (+$34.1M)

0.91% less ownership

Funds ownership: 9.85% → 8.95% (-0.91%)

31% less call options, than puts

Call options by funds: $24.8M | Put options by funds: $35.9M

Holders
193
Holders Change
+28
Holders Change %
+16.97%
% of All Funds
2.79%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
51
Increased
63
Reduced
46
Closed
21
Calls
$24.8M
Puts
$35.9M
Net Calls
-$11.1M
Net Calls Change
-$13.2M

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$9.28M
2
UBS AM
UBS AM
Illinois
+$9.2M
3
BlackRock
BlackRock
New York
+$6.91M
4
First Trust Advisors
First Trust Advisors
Illinois
+$5.85M
5
AWM
Accurate Wealth Management
Florida
+$3.69M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$41.7M
2
Invesco
Invesco
Georgia
-$7.95M
3
Citigroup
Citigroup
New York
-$6.72M
4
Rafferty Asset Management
Rafferty Asset Management
New York
-$5.77M
5
PA
Perceptive Advisors
New York
-$5.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
CM
101
Caption Management
Oklahoma
$165K -$314K -47,622 -65%
LCM
102
Laurion Capital Management
New York
$158K +$165K +25,069 New
Allianz Asset Management
103
Allianz Asset Management
Germany
$158K +$165K +25,000 New
JSSH
104
J. Safra Sarasin Holding
$158K +$165K +25,000 New
Vontobel Holding
105
Vontobel Holding
Switzerland
$152K +$158K +24,000 New
SFI
106
Susquehanna Fundamental Investments
Pennsylvania
$147K +$153K +23,185 New
XT
107
XTX Topco
Cayman Islands
$143K -$90.5K -13,732 -38%
HWM
108
HB Wealth Management
Georgia
$142K +$148K +22,500 New
TRCT
109
Tower Research Capital (TRC)
New York
$137K +$25.2K +3,826 +21%
CFM
110
Catalyst Funds Management
Australia
$137K +$142K +21,600 New
Pictet Asset Management
111
Pictet Asset Management
Switzerland
$136K – – –
Mirae Asset Global Investments
112
Mirae Asset Global Investments
South Korea
$135K -$256K -38,764 -65%
KI
113
Kapitalo Investimentos
Brazil
$127K +$133K +20,170 New
CA
114
Continuum Advisory
Idaho
$127K – – –
CC
115
Courier Capital
New York
$126K – – –
Victory Capital Management
116
Victory Capital Management
Texas
$126K +$18.1K +2,746 +16%
Mercer Global Advisors
117
Mercer Global Advisors
Colorado
$126K +$131K +19,904 New
CIBC Asset Management
118
CIBC Asset Management
Ontario, Canada
$118K +$123K +18,704 New
CCM
119
Carlson Capital Management
Minnesota
$118K +$5.34K +810 +5%
Commonwealth Equity Services
120
Commonwealth Equity Services
Massachusetts
$115K +$47K +7,135 +65%
SPC
121
Sigma Planning Corp
Michigan
$112K +$32.1K +4,875 +38%
IWC
122
Integrated Wealth Concepts
Massachusetts
$108K +$113K +17,158 New
RJFSA
123
Raymond James Financial Services Advisors
Florida
$107K +$10.5K +1,600 +10%
Dimensional Fund Advisors
124
Dimensional Fund Advisors
Texas
$105K +$109K +16,580 New
WIP
125
WealthCare Investment Partners
Rhode Island
$104K – – –
3 4
5
6 7

IBRX Hedge Fund Activity: Q2 2024 in Review

193 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q2 2024, worth a combined $391M — up 9.6% from $357M a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new IBRX positions and 21 closed out — a net gain of 30 holders — while 63 added to existing stakes and 46 trimmed.

The largest buyer was Jane Street, adding an estimated $9.28M. The largest seller was State Street, cutting an estimated $41.7M.

  • 193 institutional investors held ImmunityBio (IBRX) as of Q2 2024, up from 165 in Q1 2024.
  • Funds reported $391M of ImmunityBio stock for Q2 2024, up 9.6% quarter-over-quarter.
  • 51 funds opened new ImmunityBio positions in Q2 2024 and 21 closed out, a net change of +30 holders.
  • The largest ImmunityBio buyer in Q2 2024 was Jane Street, an estimated $9.28M added.
  • The largest ImmunityBio seller in Q2 2024 was State Street, an estimated $41.7M sold.

Based on aggregated 13F filings for Q2 2024.